Subcutaneous allergen specific immunotherapy: best clinical practice as cornerstone for future development

Area of Science:

• Immunology
• Allergy and Clinical Immunology
• Respiratory Medicine

Background:

• Allergen subcutaneous immunotherapy is a lengthy treatment for allergic respiratory diseases.
• It can alter the disease's natural progression.
• A minimum of three years of administration is typically recommended.

Purpose of the Study:

• This review focuses on subcutaneous immunotherapy.
• It discusses crucial aspects of daily management during long-term therapy.
• Key areas include side effect management and patient adherence.

Main Methods:

• Review of current literature and clinical guidelines on subcutaneous immunotherapy.
• Analysis of strategies for managing side effects.
• Examination of methods to improve and monitor patient adherence.

Main Results:

• Subcutaneous immunotherapy requires a minimum three-year treatment duration.
• Effective management hinges on proactive side effect prevention and treatment.
• Sustained patient adherence is critical for treatment success.

Conclusions:

• Subcutaneous immunotherapy is a valuable long-term therapeutic option for allergic respiratory diseases.
• Successful outcomes depend on diligent management of side effects and robust patient adherence.
• This review highlights key considerations for optimizing subcutaneous immunotherapy protocols.